Two cases of transiently TSBAb-positive hypothyroidism induced by interferon-alpha therapy for chronic hepatitis C

Endocrine Journal

Volumn 44, Issue 4, 1997, Pages 541-546

  Hayakawa, Tetsuo ^a,b   Nagai, Yukihiro ^b   Ohsawa, Kensou ^b   Taniguchi, Masayuki ^a   Koike, Nobuhiko ^a   Notsumata, Kazuo ^a   Nakamura, Saburou ^a   Ikeda, Takayuki ^a   Kobayashi, Ken Ichi ^b  

^a Tsuruga City Hospital   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Hypothyroidism; Interferon; Thyroid stimulation blocking antibody

Indexed keywords

ALPHA INTERFERON; THYROTROPIN;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHRONIC HEPATITIS; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HORMONAL REGULATION; HUMAN; HYPOTHYROIDISM; LYMPHOCYTIC INFILTRATION; SUBSTITUTION THERAPY; THYROID DISEASE; THYROID HORMONE RELEASE;

EID: 0030886930     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.44.541     Document Type: Article

References (19)

1. Berris B, Feinman SV (1991) Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 36: 1657-1660.
2. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH (1992) Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 102: 2155-2160.
3. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N (1994) The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Am J Gastroenterol 89: 399-403.
4. Kodama T, Katabami S, Kamijo K, Katanuma A, Yamashita K, Azuma N, Tamaki T, Yachi A (1994) Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. J Gastroenterol 29: 289-292.
5. Nagayama Y, Ohta K, Tsuruta M, Takeshita A, Kimura H, Hamasaki K, Ashizawa K, Nakata K, Yokoyama N, Nagataki S (1994) Exacerbation of thyroid autoimmunity by interferon a treatment in patients with chronic viral hepatitis: Our studies and review of the literature. Endocr J 41: 565-572.
6. Imagawa A, Itoh N, Hanafusa T, Oda Y, Waguri M, Miyagawa J, Kono N, Kuwajima M, Matsuzawa Y (1995) Autoimmune endocrine disease induced by recombinant Interferon-α therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 80: 922-926.
7. Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Neri TM, Braverman LE (1996) Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 172: 482-187.
8. Konishi J, Iida Y, Kasagi K, Misaki T, Nakashima T, Endo K, Mori T, Shinpo S, Nohara Y, Matsuura N, Torizuka K (1985) Primary myxedema with thyrotropin-binding inhibitor immunoglobulins: Clinical and laboratory findings in 15 patients. Ann Intern Med 103: 26-31.
9. Fentiman IS, Balkwill FR, Thomas BS, Russell MJ, Todd I, Bottazzo GF (1988) An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer. Eur J Cancer Oncol 24: 1299-1303.
10. Burman P, Totterman TH, Oberg K, Karlsson FA (1986) Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon. J Clin Endocrinol Metab 63: 1086-1090.
11. Gisslinger H, Gilly B, Woloszczuk W, Mayr WR, Havelec L, Linkesch W, Weissei M (1992) Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin Exp Immunol 90: 363-367.
12. Fonseca V, Thomas M, Dusheiko G (1991) Thyrotropin receptor antibodies following treatment with recombinant α-interferon in patients with hepatitis. Acta Endocrinol 125: 491-493.
13. Taniguchi Y, Murakami T, Nakanishi K, Tamai M, Matsuura B, Masumoto T, Onji M, Tajiri J, Noguchi S, Ohta Y (1992) Two cases of hypothyroidism associated with alpha-interferon therapy. Intern Med 31: 373-376.
14. 125I incorporation and thyroid hormone release by human thyroid follicles in vitro. J Clin Endocrinol Metab 77: 1439-1441.
15. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldman M (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2: 1115-1118.
16. Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldmann M (1985) Interferon-γ induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 61: 265-273.
17. Guerin V, Todd I, Hammond LJ, Bottazzo GF (1990) Suppression of HLA class II expression on thyrocytes by interferon-alpha 1. Clin Exp Immunol 79: 341-345.
18. Daniels HM, Meager A, Eddleston ALWF, Alexander GJM, Williams R (1990) Spontaneous production of tumour necrosis factor Ct and interleukin-1β during interferon-α treatment of chronic HBV infection. Lancet 335: 875-877.
19. Sugenoya A, Itoh N, Kasuga Y, Kobayashi S, Ohhashi T, Nagai N, Iida F (1995) Histopathological features of atrophic thyroiditis with blocking type-TSH binding inhibitor immunoglobulins. Endocr J 42: 277-281.